3Seong H A,Chang S K,Hun J S,et al. Efect of recombinant humanbone morphogenetic protein - 4 with carriers in rat calvarial defects. J Periodontol,2003,74 (6) :787.
4Wunder JS, Nielsen TO Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncol,2007,8 ( 8 ) : 670.
6AMBRUOSI AYAMAMOTOH, KREUTER J, et al. Body distribution of polysorbate 80 and doxorubicin - loaded [ (14) C ] poly ( buty 1 cyancacrylate) nanopaartieles after j. y. administraction in rats. J Drug Target,2005,1 3(10) :535.
7Sakanoto J,Annapragada A. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv ,2007,4 (4) :359.
8Silva GA . Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier. Surg Neurol. 2007,67 (2) :113.
7Lansdown A, Sampson B, Laupattaralmsem P, et al. Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat. Br J Dermatol, 1997, 137(5) :728-730.
8Bellinger C, Conway N. Effect of silver nitrate and sulfamylon on epithelial regeneration. Plast Reconstr Surg, 1970, 45 (3): 582-584.
9Demling RH, Leslie-DeSami MD. Effects of silver on wound management. Wounds, 2001,13 ( 1 Suppl A) : 1-3.
10Demling RH, Leslie-DeSanti MD. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver.Burns, 2002,28(3) :264-266.
